Benzinga's Top Pre-Market Gainers

Inhibitex Inc (NASDAQ: INHX) surged 149.14% to $24.59 in the pre-market session. Bristol-Myers Squibb Co (NYSE: BMY) announced its plans to buy Inhibitex for around $2.5 billion.

Idenix Pharmaceuticals Inc (NASDAQ: IDIX) added 43.97% to $10.15 in the pre-market session. IDIX reported positive interim data for HCV Nucleotide Inhibitor, IDX184.

VIVUS Inc (NASDAQ: VVUS) moved up 18.31% to $12.02 in the pre-market session. The Food and Drug Administration requested VIVUS to remove the Qnexa® contraindication for women of childbearing potential.

Netflix Inc (NASDAQ: NFLX) soared 5.41% to $90.96 in the pre-market trading. Netflix launched today in the United Kingdom and Ireland.